Please see below some additional medical research funding opportunities with current deadlines. For the Coronavirus (COVID-19) specific research grant opportunities visit the COVID-19 Funding Opportunities page.
Moore Foundation Diagnostic Excellence Initiative │ Deadline: May 10
The Gordon and Betty Moore Foundation, Diagnostic Excellence Initiative program aims to reduce harm from erroneous or delayed diagnoses, reduce costs and redundancy in the diagnostic process, improve health outcomes and save lives. The focus is acute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia), and cancer (such as lung cancer and colorectal cancer).Funding Information: $250,000 to $500,000 for work done over 18 months.Eligibility/ Restrictions: Successful applications will describe teams and partnerships that include a multidisciplinary group of experts, including clinicians with content expertise, individuals with appropriate analytic expertise (data science, statistics, measure development) and persons with experience using relevant data sources.Internal Contacts: Interested BU faculty please contact David Gillerman, Director of Foundation Relations, Boston University Medical Campus, at email@example.com or (617) 359-8089. If you are a BMC investigator, please contact Jennifer Fleming, Director of Foundation Relations and Government Grants at Jennifer.Fleming@bmc.org by Monday, April 19, 2021.Deadlines: May 10, 2021
NIH-Administrative Supplements for AI/ML Workforce Development │ Deadline: May 14
The Office of Data Science Strategy (ODSS) at NIH, in partnership with fourteen Institutes and Centers (ICs), released a Notice of Special Interest announcing the availability of Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences. The aim of this program is to fund the development and implementation of academic curricula (i.e., exportable training modules and integrated training plans) or training activities (i.e., events or other educational experiences where the structure and output are shared) at the interface of information science, AI/ML, and biomedical sciences. The ultimate goal of these supplements is to equip scientists with expertise in making biomedical data Findable, Accessible, Interoperable, and Reusable (FAIR) and AI/ML-ready. Activities supported by these supplements should be made available to the broadest possible audience, including researchers at different career stages and from different backgrounds, at no cost to the user.Award Information: Application budgets are limited to $80,000 in direct costs (plus applicable F&A costs), and requests may only be made for one year of support.Eligibility: Each participating IC has issued specific eligibility criteria for these supplements. In general, parent awards eligible for supplemental funding are institutional training grants (e.g. T32 awards) or research education program (e.g. R25) awards.Deadline: Applications are due May 14, 2021.
Cystic Fibrosis Foundation PTAC initiative │ Deadline: May 13
The projects supported through the Cystic Fibrosis Foundation PTAC initiative should focus on foundational concepts, strategies, and methods that have the potential to inform or ultimately translate into novel therapies to restore CFTR protein function or fix/replace the defective CFTR gene.Funding Information:
- PTAC Research Grants: Up to $125,000 per year plus 12 percent indirect costs for up to two years.
- PTAC Pilot & Feasibility Award: Up to $50,000 per year plus 12 percent indirect costs for up to two years.
- PTAC Postdoctoral Fellowship Award: Up to $63,350 in the first year, and up to $65,700 in the second year. Indirect costs are not allowable.
Eligibility/Restrictions: Eligibility requirements vary by award type. For more details about eligibility see individual policies and guidelines webpage.
Internal Contacts: Interested BU faculty please contact David Gillerman, Director of Foundation Relations, Boston University Medical Campus, at firstname.lastname@example.org or (617) 359-8089. If you are a BMC investigator, please contact Jennifer Fleming, Director of Foundation Relations and Government Grants at Jennifer.Fleming@bmc.org by Monday, April 19, 2021.
Deadline: May 13, 2021
NOMIS & Science Young Explorer Award │ May 15
Funding Information: $15,000 Grand Prize, $5,000 prize for runners up.
- Entrant must be under age 35
- Entrant must hold a PhD, MD, or MD/PhD at time of submission
- The submission/content must focus on work done in the past 3 years
Submission process: The entrant must submit the following items:
- A completed Entry Form.
- An essay, written by the entrant that describes their research at the intersection of the life and social sciences, showing interdisciplinary work. The essay must not exceed 1,000 words in length. The applicant must have done or directed all of the work and it must have been performed in the last three years.
- A one-page letter of recommendation from his or her postdoctoral adviser, supervisor, or other senior colleague who is familiar with the entrant’s work.
- A Curriculum Vitae that includes the following:
- Full citations of papers that the entrant has published on the research described in the essay
- Academic and professional awards and honors that the entrant has received; and
- Relevant professional experience
- Copies of two of the entrant’s papers that are most relevant to the essay.
All material must be submitted via the prize management system linked on the award page.
Deadline: Saturday, May 15, 2021.
NIH- Bridge to Artificial Intelligence (Bridge2AI) │ Deadline: August
The National Institutes of Health (NIH) announced a set of opportunities related to artificial intelligence (AI) and machine learning (ML) in the context of biomedical research. One opportunity is currently accepting proposals, and the others will open in June 2021.
Coming Soon: Opportunities through the Bridge to Artificial Intelligence (Bridge2AI) Program. NIH has released two Notices of Intent to Publish previewing upcoming funding opportunities through the new Common Fund program, Bridge to Artificial Intelligence (Bridge2AI). Bridge2AI, initially referred to by NIH as Artificial Intelligence for BiomedicaL Excellence (AIBLE), aims to promote the widespread adoption of artificial intelligence (AI) and machine learning (ML) in biomedical research. The overall goal of the program is to “generate flagship datasets and best practices for the collection and preparation of AI/ML-ready data to address biomedical and behavioral research grand challenges.” The Bridge2AI program aims to generate:
- New biomedical and behavioral datasets, that are ethically sourced, trustworthy, well-defined and accessible;
Software to standardize data attributes across multiple data sources and across data types (establishing new standards as needed);
- Automated tools to assist the creation of FAIR and ethically sourced datasets (e.g.: through the intelligent workflows, sensorized instruments, etc.);
- Resources to disseminate data, ethical principles, tools and best practices; and
- Cross-training materials and activities for workforce development that bridges the AI/ML and biomedical/behavioral research communities.”
NIH plans to publish full solicitations in June 2021 for the first two components of Bridge2AI:
Data Generation Projects of the NIH Bridge to Artificial Intelligence (Bridge2AI) Program: NIH will use Other Transaction Authority (OTA) to fund multidisciplinary data generation projects, which will produce the flagship datasets at the heart of Bridge2AI. Each project will be centered around a biomedical and/or behavioral research “grand challenge,” and will be expected to produce multiscale, multimodal, and multi-stream datasets that can be used in AI/ML analyses. Several examples of potential “grand challenges” that could be addressed through these awards are included in the Notice of Intent to Publish. Project teams should include participants from multiple scientific domains and diverse social, cultural, economic, academic, and industrial backgrounds and communities.
NIH Bridge2AI Integration, Dissemination, and Evaluation (BRIDGE) Center: NIH will use the U54 Cooperative Agreement mechanism to fund a BRIDGE Center to coordinate and integrate activities across the Data Generation Projects, including disseminating products, best practices, and skills and workforce development materials, as well as evaluating all aspects of the Bridge2AI program. The Center will be structured as a series of Cores – one Administrative and five Scientific – that will work together and with other components of Bridge2AI. The planned Scientific Cores focus on Teaming; Ethics; Standards; Tool Optimization and Dissemination; and Skills and Workforce Development. Applicants must propose creating an Administrative Core and at least one of these Scientific Cores to be considered for funding. Each proposed Core will be individually reviewed, and the BRIDGE Center may be assembled of Cores from different institutions.
Publication: NIH anticipates releasing the full solicitations for both of the above opportunities on June 11, 2021.
Deadline: The first anticipated application due date will be in August 2021. Potential applicants for the Data Generation Projects will be required to participate in NIH-facilitated teaming activities in summer 2021 as part of the application process. Information on these teaming activities will be published on NIH’s Bridge2AI website in the coming months.
Award Information: The earliest anticipated award date will be in March 2022. At this time, the estimated funding total for the program, the number of awards to be made, and the size of each award are all to be determined.
Eligibility: All institutions of higher education, non-profits, for-profit organizations, state and local governments, and Indian/Native American Tribally Designated Organizations will be eligible to apply.
Massachusetts Life Sciences Center - Accelerating Coronavirus Testing Solutions │ Deadline: Ongoing Submission
By any measure, Massachusetts’ life sciences ecosystem is one of the most robust in the world. Whether you measure public or private investments, top research universities and academic medical centers, STEM education, R&D infrastructure, talent, or life science companies, Massachusetts leads the way in bringing healthcare innovations to patients. This life science community can positively and quickly continue to impact the current COVID-19 pandemic. The Massachusetts Life Sciences Center is in a unique position to accelerate this impact by identifying, supporting, and funding novel innovations and solutions for SARS-CoV-2 testing. The Center is soliciting proposals for the Accelerating Coronavirus Testing Solutions (A.C.T.S.) program to improve testing solutions and address supply chain logistics bottlenecks during this critical time to ensure the safety of its constituents and the world. This project call will leverage Massachusetts’ R & D capabilities and innovation infrastructure to accelerate the development of improved testing modalities and address supply chain logistical bottlenecks that hinder our ability to quickly and effectively combat and contain the COVID-19 pandemic. The MLSC is requesting proposals to address the gaps that currently exist in SARS-CoV-2 testing. Projects funded under this grant may fall into one of the two priority response areas: Development of Rapid, Innovative At-Home or Point-of-Care Testing Modalities: We aim to support testing innovations that are easier and quicker to perform and can be done by patients outside of a healthcare practitioner’s office.
- Solutions that provide a low-cost, surveillance testing technology that can be deployed independently of CLIA approval or medical personnel oversight are encouraged. Solutions that cost less than $10 per test are of particular interest.
- Solutions that will provide a low-cost test with greater than 75% sensitivity and ideally 95% specificity are encouraged.
Addressing Supply Chain Bottlenecks: Innovations or increased novel manufacturing capacity that can address the supply chain bottlenecks for existing platforms are encouraged to apply. The MLSC is aiming to support the development of novel technologies to address the lack of specialized plastic ware and development of generic reagents and supplies to allow labs across the Commonwealth to fully utilize and leverage their existing high throughput testing platforms. To the extent that applicants are proposing supply chain solutions to a closed system, which involves proprietary technology, applicants will need to demonstrate that they have taken into consideration the requirement for any necessary approvals from the manufacturer of the proprietary system.
Funding: No specified award amount.
Eligibility & Restrictions: Applicants can be Massachusetts-based for-profit companies or non-profit institutions, which includes research institutions, academic medical centers, and colleges and universities. Municipalities or other governmental entities are NOT eligible to apply.
- Each application must be authorized by a senior leader of the applying organization (e.g., President, CEO, Executive Director, Dean, Chancellor, etc.).
- Applications should focus on developing innovative low cost “at home” or point of care testing modalities or addressing supply chain bottlenecks or logistical issues for testing SARS-CoV-2. Generally, the MLSC funds support life sciences as defined as: Advanced and applied sciences that expand the understanding of human physiology and have the potential to lead to medical advances or therapeutic applications including, but not limited to, agricultural biotechnology, bio-generics, bioinformatics, biomedical engineering, biopharmaceuticals, biotechnology, chemical synthesis, chemistry technology, diagnostics, genomics, image analysis, marine biology, marine technology, medical devices, nanotechnology, natural product pharmaceuticals proteomics, regenerative medicine, RNA interference, stem cell research, and veterinary science.
- Project requests must be fully justified. The requested funds can only be used to support direct labor and capital costs (e.g., equipment, supplies) related to the project. Updated 10/6/20 Applicants must explore all options for funding and equipment requests (e.g., loaning equipment from a neighboring institution or partner, internal funding, etc.).
Internal Selection process: As the opportunity does not have a limit on institutional submissions, the Office of Research is not conducting any internal selection process. Interested applicants may contact Marc Scatamacchia in Industry Engagement at email@example.com for guidance and support. If you are a BMC investigator and wish to apply for this opportunity, please contact Jennifer Fleming, Director of Foundation Relations and Government Grants at firstname.lastname@example.org by Friday, Oct. 16, 2020.
Deadlines: Sponsor Deadline: Friday, October 16, 2020. Rolling deadline, initial deadline is 10/16/2020. Subsequent deadlines every 2 weeks after that.
NIH/CDC - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) │ Deadline: Varies
The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) announce available funds for administrative supplements to recruit and support postdoctoral fellows and/or junior faculty-level candidates from diverse backgrounds including those from underrepresented groups in health-related research.These supplements are to support individuals who wish to participate as researchers in ongoing research projects and career development experiences in preparation for an independent career in health-related research. This experience must serve as a means of assisting the researcher’s development into a productive researcher in health-related science.Eligibility: Parent award must be active and the research proposed in the supplement must be accomplished within the scope of the award. NIH defines underrepresented populations in the U.S. Biomedical Clinical Behavioral and Social Sciences Research Enterprise as Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders, as well as individuals with disabilities or disadvantaged backgrounds.Project Period: Must be within the currently approved project period for an existing parent award.
Award: Direct costs awards range from $5,000-$100,000 depending on career level of the candidate. Administrative supplements can be used to cover cost increases that are associated with achieving the new research objectives that are within the original scope of the peer reviewed and approved project, or for cost increases of unanticipated expenses within the original scope of the project.Deadlines: Vary by awarding NIH Institutes and Centers.Internal Contact: Interested applicants may contact Amanda Miner for support at email@example.com in the Proposal Development Office.